Table 4 Comparison of treatment received at diagnosis and last visit
Variables | At diagnosis | At last visit (ever use) | |||||
|---|---|---|---|---|---|---|---|
Late-onset SLE (N = 62) | Early-onset SLE (N = 124) | p value | Late-onset SLE (N = 62) | Early-onset SLE (N = 124) | p1 value | p2 value | |
Prednisolone | Â | Â | Â | Â | Â | Â | Â |
≥ 0.5 mg/kg/day, n (%) | 50 (80.6) | 92 (74.2) | 0.329 | 56 (90.3) | 112 (90.3) | 0.972 | 0.476 |
IVMP, n (%) | 3 (4.8) | 4 (3.2) | 0.586 | 5 (8.1) | 20 (16.1) | 0.107 | 0.057 |
Antimalarial drug, n (%) | 33 (53.2) | 84 (67.7) | 0.053 | 42 (67.7) | 106 (85.5) | 0.023 | 0.144 |
Immunosuppressive drug, n (%) | 22 (35.5) | 32 (25.8) | 0.170 | 38 (61.3) | 97 (78.2) | 0.044 | 0.005 |
Methotrexate, n (%) | 3 (4.8) | 4 (3.2) | 0.586 | 7 (11.3) | 17 (13.7) | 0.797 | 0.574 |
Azathioprine, n (%) | 4 (6.5) | 6 (4.8) | 0.646 | 14 (22.6) | 63 (50.8) | 0.001 | 0.001 |
Cyclophosphamide, n (%) | 11 (17.7) | 19 (15.3) | 0.672 | 18 (29.0) | 60 (48.4) | 0.028 | 0.006 |
Calcineurin inhibitors, n (%) | 0 | 0 | Â | 2 (3.2) | 19 (15.3) | 0.039 | 0.039 |
Mycophenolate mofetil, n (%) | 7 (11.3) | 4 (3.2) | 0.028 | 14 (22.6) | 53 (42.7) | 0.026 | 0.002 |